PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
23.11%
Some net income increase while AVGO is negative at -203.80%. John Neff would see a short-term edge over the struggling competitor.
1.43%
Less D&A growth vs. AVGO's 321.31%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
247.68%
Some yoy growth while AVGO is negative at -250.00%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
5.88%
Less SBC growth vs. AVGO's 83.33%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
37.81%
Less working capital growth vs. AVGO's 7400.00%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
58.62%
AR growth is negative or stable vs. AVGO's 175.00%, indicating tighter credit discipline. David Dodd would confirm it doesn't hamper sales volume.
62.52%
Inventory shrinking or stable vs. AVGO's 1533.33%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-111.56%
Both negative yoy AP, with AVGO at -387.50%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
24.60%
Some yoy usage while AVGO is negative at -1160.00%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-17.20%
Negative yoy while AVGO is 450.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
68.26%
Operating cash flow growth above 1.5x AVGO's 25.10%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
55.10%
Some CapEx rise while AVGO is negative at -30.14%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-22.83%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-70.35%
Both yoy lines are negative, with AVGO at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-100.13%
Both yoy lines negative, with AVGO at -100.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-126.32%
Both yoy lines negative, with AVGO at -9627.12%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-3.04%
We cut debt repayment yoy while AVGO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Buyback growth of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.